Denis Y Logunov, DSc, Inna V Dolzhikova, PhD, Dmitry V Shcheblyakov, PhD, Amir I Tukhvatulin, PhD, Olga V Zubkova, PhD, Alina S Dzharullaeva, MSc, Anna V Kovyrshina, MSc, Nadezhda L Lubenets, MSc, Daria M Grousova, MSc, Alina S Erokhova, MSc, Andrei G Botikov, MSc, Fatima M Izhaeva, MSc, Olga Popova, MSc, Tatiana A Ozharovskaya, MSc, Ilias B Esmagambetov, PhD, Irina A Favorskaya, PhD, Denis I Zrelkin, MSc, Daria V Voronina, MSc, Dmitry N Shcherbinin, PhD, Alexander S Semikhin, PhD, Yana V Simakova, MSc, Elizaveta A Tokarskaya, PhD, Daria A Egorova, PhD, Maksim M Shmarov, DSc, Natalia A Nikitenko, PhD, Vladimir A Gushchin, PhD, Elena A Smolyarchuk, PhD, Sergey K Zyryanov, DSc, Sergei V Borisevich, DSc, Prof Boris S Naroditsky, DSc, Prof Alexander L Gintsburg, DSc, and theGam-COVID-Vac Vaccine Trial Group. (2021) Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet. DOI: https://doi.org/10.1016/S0140-6736(21)00234-8
Lindsey R. Baden, M.D., Hana M. El Sahly, M.D., Brandon Essink, M.D., Karen Kotloff, M.D., Sharon Frey, M.D., Rick Novak, M.D., David Diemert, M.D., Stephen A. Spector, M.D., Nadine Rouphael, M.D., C. Buddy Creech, M.D., John McGettigan, M.D., Shishir Khetan, M.D., et al. for the COVE Study Group (2020) Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine.DOI: 10.1056/NEJMoa2035389